首页> 美国卫生研究院文献>Journal of the Canadian Association of Gastroenterology >A218 LISTERIA MONOCYTOGENES MENINGITIS IN A NEWLY DIAGNOSED PATIENT WITH INFLAMMATORY BOWEL DISEASE: A CASE REPORT
【2h】

A218 LISTERIA MONOCYTOGENES MENINGITIS IN A NEWLY DIAGNOSED PATIENT WITH INFLAMMATORY BOWEL DISEASE: A CASE REPORT

机译:初诊为炎症性肠病的A218单核细胞增生性李斯特菌:病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Anti-Tumor Necrosis Factor (TNF) is a frequently utilized therapy in the treatment of Inflammatory Bowel Disease (IBD). Opportunistic infections are a known but an infrequently encountered complication. ) is an aerobic gram-positive intracellular bacillus. Clinical presentation of infection is host dependent, ranging from self-limited illnesses in immunocompetent individuals to life-threatening sepsis and meningitis in the immunocompromised. TNF plays a crucial role in host’s defense against . Although published in adults, few case reports have documented invasive in children receiving infliximab (IFX), an anti-TNF agent used in IBD therapy.
机译:抗肿瘤坏死因子(TNF)是治疗炎症性肠病(IBD)的常用方法。机会感染是已知的但很少见的并发症。 )是一种需氧革兰氏阳性细胞内芽孢杆菌。感染的临床表现取决于宿主,范围从免疫能力强的个体的自限性疾病到免疫受损的威胁生命的败血症和脑膜炎。 TNF在宿主防御中起着至关重要的作用。尽管已在成人中发表,但很少有病例报告记录到接受英夫利昔单抗(IFX)的儿童的侵袭性,英夫利昔单抗是一种用于IBD治疗的抗TNF药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号